An endotoxin inhibitor derived from cinnamon bark was characterized chemically and tested for anti-LPS properties. Chemical analysis suggested that the active center of the inhibitor was in the lipid portion. Upon incubation with LPS molecule, the inhibitor reduced the ability of LPS to induce TNFα and generate nitric oxide from various cells in vitro, and Limulus gelation activity. The lethal toxicity of LPS in galactosamine-sensitized mice and pyrogenicity of LPS in a rabbit model were reduced 1000-and 100-fold by pre-incubation with the inhibitor, respectively. Simultaneous but separate injection of the inhibitor with a lethal dose of LPS also protected the majority of mice. Protection against LPS was seen when the inhibitor was given to mice 1 h before the LPS challenge. Furthermore, the inhibitor significantly suppressed the induction of fever by simultaneous administration with LPS without prior mixing. These results suggest that the inhibitor may be a useful potent blocker of bacterial endotoxin.
INTRODUCTION
Endotoxin plays a principal role in Gram-negative bacterial infections leading to severe pathogenic changes such as fever, hypotension, shock, disseminated intravascular coagulation, and multiple organ failure. Despite the major clinical problems associated with endotoxicosis, there are only a limited number of treatment options, including antibodies against the LPS molecule, 1,2 cytokines induced by LPS, 3, 4 and LPS receptors 5, 6 and antagonists. [7] [8] [9] All of these methods, however, entail theoretical or practical difficulties, and they are, as yet, unavailable for use. LPSneutralizing agents are potential candidates for treatment of endotoxicosis. Several proteins which bind to the LPS molecule and neutralize its action have been recently reported, including cationic antimicrobial protein and bactericidal/permeability-increasing protein derived from granulocytes, 10, 11 lactoferrin present in polymorphonuclear leukocytes, 12 and lipoproteins in serum. 13, 14 Other LPS-binding proteins have also been found in the Limulus amoebocyte, 15 hemolymph of the American cockroach, 16 bee venom, 17 and polymyxin B, 18 all of which have also been shown to have in vitro anti-endotoxin actions. However, use of these compounds for treatment of septic shock 19 is limited, mainly due to high toxicity. 20, 21 All of these inhibitors are proteins or lipoproteins.
We have isolated a potent endotoxin inhibitor for the first time from plant. This inhibitor suppressed the Limulus gelation activity of LPS in a concentration-and time-dependent manner, suggesting that inhibition was due to direct interaction of the inhibitor with the LPS molecule. Unlike all other LPS-neutralizing compounds found to date, this inhibitor was lipophilic.
In the present report, we have chemically characterized the inhibitor and examined its anti-LPS activity both in vitro and in vivo. We show that the inhibitor prevents LPS effects in vivo even when it was administered prior to LPS challenge in LPS shock model animals.
MATERIALS AND METHODS

Extraction and purification of the inhibitor from cinnamon bark
The procedure for extraction of this novel compound has been described by Azumi et al. 22 In brief, the inhibitor was extracted from 100 g of cinnamon bark (Matsuura Yakugyo, Nagoya, Japan) with 1 litre of 67% ethanol in water for 4 days followed by evaporation to dryness. The extract was purified by gel filtration chromatography with a Sephadex G-50 column (12 cm × 90 cm) equilibrated with 40% ethanol in 0.2 M glycine/NaOH buffer (pH 10.6) with the same solvent as the eluent. Elution was carried out at 10 ml/h, and the active fraction (G-EI) was obtained by measuring the inhibition of Limulus gelation activity of LPS. LPS from Salmonella minnesota (S form) was used as a standard throughout the experiments in the present study, which was obtained by extraction using the aqueous phenol method. 23 
Chemical analysis
Protein and neutral sugar were measured by the Coomassie brilliant blue method 24 and phenol/H 2 SO 4 method, 25 respectively. The lipid content was estimated by weighing the extract with chloroform after hydrolysis of the test sample for 24 h at 100°C with 6 M HCl. 26 Amino acid analyses were performed with an L-8500 amino acid analyzer (Hitachi) after hydrolysis (110°C, 24 h) in 6 M HCl containing 1% phenol.
Limulus amoebocyte gelation assay
Activation of the proclotting enzyme of the horseshoe crab, Limulus polyphemus, was estimated colorimetrically by measuring the absorbance of p-nitroaniline released from a synthetic substrate in a quantitative assay (Endospecy; Seikagaku Kogyo, Tokyo, Japan). The assay was performed in 96-well Costar flat plates at 37°C for 30 min, and the chromogen was measured at 405 nm using a microplate reader (Molecular Devices, Sunnyvale, CA, USA). Pyrogen-free water was used to dilute the test samples (Otsuka Seiyaku, Tokyo, Japan).
Inhibition assay of Limulus amoebocyte gelation activity of LPS
An inhibition assay of Limulus gelation activity of LPS was performed as follows if not stated otherwise. The same volume of a solution of LPS (S. minnesota S form) in water and inhibitor in 40% ethanol/0.2 M glycine-NaOH buffer (pH 10.6) were mixed with various concentration combinations. After a 30 min incubation at room temperature, the mixture was diluted to a concentration of 100 pg of LPS per ml with pyrogen-free water, and the Limulus gelation activity was measured as described above. A standard curve for calculating the inhibition activity was made by plotting the time to reach a certain optical density (OD) by various concentrations of LPS alone. The apparent LPS concentration of the test sample was obtained from the standard curve by measuring the time to reach the same OD by the test sample, and the inhibition rate was calculated as the ratio of apparent versus true LPS concentration.
Induction of TNFα and nitric oxide (NO) release from mouse peritoneal macrophages, J774-1, and THP-1 cells
Mouse peritoneal macrophages were obtained by washing the peritoneal cavity of female BALB/C mice (6-10 weeks old) with 5 ml of serum-free Iscove's medium. 27, 28 The cell number was adjusted to 2 x 10 6 cells/ml. After adhesion, the cells were incubated with the stimulant for 6 h. J774-1 and THP-1 line cells were obtained from the Japanese Cancer Research Resources Bank (JCRB). They were grown in RPMI 1640 medium (Gibco Laboratories, Grand Island, NY, USA) supplemented with 10% (v/v) heat-inactivated fetal calf serum (FCS), 50 µM 2-mercaptoethanol, 5 mM HEPES, penicillin (100 units/ml) and streptomycin (100 µg/ml) in a 5% CO 2 atmosphere at 37°C. J774-1 cells were harvested by scraping with a cell scraper (Costar) and suspended in fresh medium. The cells (1 x 10 6 cells/ml per well of 24-well dishes) were allowed to adhere to plastic for 3 h at 37°C, washed twice with medium, and incubated for an additional 4 h for TNFα induction and 72 h for NO induction with the stimulant. THP-1 cells (2 x 10 5 cells/ml per well of 24-well dishes) were prepared by adding 100 ng/ml of PMA (Sigma, St Louis, MO, USA) and 0.1 µM 1,25-dihydroxy vitamin D 3 (Wako Pharmaceutical Co., Tokyo, Japan) to cell suspensions in RPMI 1640/10% FCS. 29, 30 The cell suspensions were allowed to differentiate and adhere to plastic for 72 h at 37°C. After washing, the cells were incubated for an additional 24 h with the stimulant. The supernatants of test samples were stored at -80°C until determination of TNFα or NO.
TNFα assay
The TNFα produced was determined by L929 cytotoxicity assay. Recombinant TNFα standards and rabbit polyclonal antisera against murine TNFα were obtained from Asahi Kasei Kogyo, Ltd (Japan). L929 murine fibroblasts were grown in tissue culture flasks in RPMI 1640 medium. Cells were detached with trypsin, washed, resuspended in medium at 4 x 10 5 cells/ml, and 100 µl aliquots were plated in 96-well flat-bottomed plates (Corning). After incubation for 3-5 h at 37°C in 5% CO 2 , 50 µl of actinomycin D (4 µg/ml) in RPMI medium was added to each well, and 50 µl of test sample was then added to the wells (final volume; 200 µl/well). The experiments were performed in triplicate.
NO assay
NO was measured as a stable form of nitrite (NO 2 -) in the supernatant using Griess reagent. 31 Briefly, 100 µl volumes of test sample were mixed with the same volume of Griess reagent (1: PO 4 ) in a 96-well plate, and the absorbance was read at 550 nm with a microplate reader.
Lethal toxicity test
The lethality test was performed according to the method described by Galanos et al. 32 using female C57BL/6 mice more than 10-weeks-old obtained from Nihon SLC (Hamamatsu, Japan). Test samples in 0.1 ml of pyrogen-free water were injected intravenously immediately after intraperitoneal administration of 12 mg of D-galactosamine (Sigma) in 0.5 ml of pyrogenfree PBS if not stated otherwise.
Pyrogenicity
Pyrogenicity was tested using Japanese White rabbits (Oriental Yeast, Tokyo) weighing 2.6-3.1 kg and bred under specific-pathogen-free conditions. The test was performed in an air-conditioned room. Three animals were used for each sample. They were injected intravenously with 10 ml/kg of test sample dissolved in pyrogen-free saline. Fever was measured rectally using thermistor probes connected to a recording temperature-measuring device and expressed as the increase in temperature (∆T). The mean temperature rise was calculated.
RESULTS
Characterization of the active center of the inhibitor
Several chemical and enzyme treatments were used to clarify the chemical properties of the active center of G-EI, and the LPS-inhibitory activity was tested using the Limulus test. Treatments including proteinase K (Seikagaku Kogyo, Tokyo, Japan) for 24 h at 37°C, reduction with 0.08 M NaIO 4 in 0.05 M sodium acetate (pH 4.0) for 4 days in the dark, and heating in water solution at 100°C for 1 h failed to reduce the inhibitory activity of the inhibitor (data not shown). Since these results suggested that the active center of G-EI resided in the lipophilic portion, G-EI was, therefore, phase-separated with chloroform/ethanol/water (2:2:3, v/v), and each chloroform and water layer was tested for Limulus gelation inhibitory activity of LPS and compared to that of G-EI. Inhibitory activity was tested by mixing LPS with the inhibitor for 30 min prior to the Limulus assay in various concentration combinations. The results are shown in Table 1 . The inhibition increased depending on the concentration of the inhibitor, and was inversely proportional to the LPS concentration when the inhibitor and LPS was mixed. G-EI at 0.1 mg/ml, 1 mg/ml, and 10 mg/ml inhibited the activity of S. minnesota LPS by almost or more than 90% at 10 ng/ml, 1 µg/ml, and 1 mg/ml, respectively. The inhibition was expressed without regard to the final concentration of the inhibitor added to the assay system, indicating that the residual free inhibitor does not induce the inhibition by affecting the assay system. The chloroform layer (EIL) had stronger inhibitory activity than the G-EI at any concentration. Only negligible inhibitory activity was observed with the water layer (data not shown).
The chemical composition of G-EI and EIL was analyzed. G-EI contained 48.6% lipid, 17% protein, and 18% neutral sugar, whereas EIL contained negligible amounts (0.05%) of protein according to the estimation by amino acid analysis, and 5% neutral sugar.
Anti-endotoxin properties of a cinnamon bark-derived compound 111 
Reduction of TNFα-inducing activity of LPS from mouse peritoneal macrophages, J774-1, and THP-1 cells, and NO from J774-1 cells by the pre-incubation with G-EI and EIL
The action of the inhibitor on the TNFα-inducing activity of LPS from various cells was tested by mixing 20 µg/ml of LPS with 10 mg/ml of either G-EI, or EIL for 30 min prior to the assay, and the mixture was diluted to a final concentration of 1 and 10 ng/ml of LPS for the stimulation of the cells. LPS solution without the inhibitor was used as a positive control. Mouse peritoneal macrophages were found to react to stimulation by LPS as shown in Figure 1 , and produced 10.2 ng/ml and 12.5 ng/ml of TNFα at LPS concentrations of 1 and 10 ng/ml, respectively. The activity of LPS was reduced when it was co-incubated with either G-EI or EIL prior to addition to the cells. The inhibitory action of EIL was stronger than that of G-EI, and suppressed activity of 1 ng/ml and 10 ng/ml of LPS to 25% and 14%, respectively. The same experiment was performed using J774-1 cells. As shown in Figure 2 , a similar effect of the inhibitor was observed. The cells produced 2.4 ng/ml of TNFα at an LPS concentration of 1 ng/ml and the activity was completely suppressed by both G-EI and EIL. At an LPS dose of 10 ng/ml, 63% and 83% of the activity was suppressed by these inhibitors, respectively. Fig. 1 . Reduction of TNFα-inducing activity of LPS from mouse peritoneal macrophages by pre-incubation with G-EI and EIL. A total of 10 mg/ml of G-EI or EIL was mixed with 20 µg/ml of LPS. After a 3 h incubation, the mixture was diluted to 1 and 10 ng/ml of LPS. Mouse peritoneal macrophages (2 x 10 6 cells/ml/well) were incubated with the test sample for 6 h and the supernatants were assayed for TNFα. TNFα was determined with the L929 cytotoxicity assay. The results are expressed as means ± SD of triplicate experiments. Values represent the mean concentration of TNFα ± standard deviation for triplicate wells from one of two experiments with similar results. Significance and P values were obtained by paired t-test: **P < 0.01 versus the LPS alone; ++P < 0.01 versus the LPS/G-EI ratio.
Fig. 2.
Reduction of TNFα-inducing activity of LPS from J774-1 cells by pre-incubation with G-EI and EIL. A total of 10 mg/ml of G-EI or EIL was mixed with 20 µg/ml of LPS. After a 3 h incubation, the mixture was diluted to 1 and 10 ng/ml of LPS. J774-1 cells (1 x 10 6 cells/ml/well) were incubated with the test sample for 3 h and the supernatants were assayed for TNFα. TNFα was determined with the L929 cytotoxicity assay. Values represent the mean concentration of TNFα ± standard deviation for triplicate wells from one of three experiments with similar results. Significance and P values were obtained by paired t-test: *P < 0.05 versus the LPS alone; **P < 0.01 versus the LPS alone. Fig. 3 . Reduction of TNFα-inducing activity of LPS from THP-1 cells by pre-incubation with G-EI and EIL. A total of 10 mg/ml of G-EI or EIL was mixed with 200 µg/ml of LPS. After a 3 h incubation, the mixture was diluted to 100 ng/ml of LPS. THP-1 cells (2 ± 10 5 cells/ml/well) were incubated with the test sample for 24 h and the supernatant were assayed for TNFα. TNFα was determined with the L929 cytotoxicity assay. Values represent the mean concentration of TNFα ± standard deviation for triplicate wells from one of three experiments with similar results. Significance and P values were obtained by paired t-test: **P <0.01 versus the LPS alone.
The human monocytic cell line THP-1 reacted to stimulation with S. minnesota LPS, and produced 6.0 ng/ml of TNFα at a concentration of 100 ng/ml. This LPS activity was reduced to 57% and 37% by pre-incubation with either G-EI or EIL, respectively ( Fig. 3) . Therefore, the inhibitory activity of EIL for the induction of TNFα by LPS was consistently stronger than that of G-EI in all test systems.
The inhibitory action of the inhibitor against NOinducing activity of LPS on J774-1 cells was tested by mixing 20 µg/ml of LPS with 10 mg/ml of G-EI or EIL for 3 h prior to the assay. The mixture was diluted to a final concentration of 1, 10, and 100 ng/ml of LPS for the stimulation of cells. The cells were found to react to stimulation by LPS as shown in Figure 4 and produced 3.3, 26.3, and 35.8 µM of NO at an LPS concentration of 1, 10, and 100 ng/ml, respectively. The NO production by each concentration of LPS was reduced by pre-incubation with G-EI to less than 2.5, 10.0 and 21.0 µM, respectively. Similar reduction of LPS activity was also observed by pre-incubation with EIL ( Fig. 4) .
Reduction of lethal toxicity of LPS in galactosaminesensitized mice by pre-incubation with EIL
To corroborate the in vitro inactivation of LPS by the inhibitor, the inhibitory activity of G-EI and EIL on the lethal toxicity of LPS was tested using galactosamine-sensitized mice. In this system, LPS alone from S. minnesota exhibited 75% lethality at 10 ng/mouse and 100% lethality at 100 ng/mouse ( Table 2 ). This activity of the LPS was drastically reduced when 200 µg/ml of LPS and 100 mg/ml of G-EI were incubated for 3 h prior to administration. No lethality was expressed at 0.1 µg/mouse, and significant lethality (75%) was first observed at a dose of 1 µg/mouse of LPS treated by G-EI, indicating that the lethal toxicity of the LPS had been reduced about 100-fold by G-EI pretreatment. Markedly more pronounced inhibition was observed when LPS was treated with EIL. In this case, no lethality was exhibited even at 10 µg/mouse of LPS prepared as a mixture of 200 µg/ml of LPS and 100 mg/ml of EIL, showing a 1000-fold reduction in activity. Even when 200 µg/ml of LPS was mixed with 10 mg/ml of EIL, lethality (71%) was first recognized at an LPS dose of 10 µg/mouse, confirming a 1000-fold reduction in LPS activity.
Reduction of LPS pyrogenic activity in rabbits by preincubation with G-EI and EIL
Pyrogenicity in the rabbit is another in vivo assay system for LPS activity. The action of the inhibitor on pyrogenic Anti-endotoxin properties of a cinnamon bark-derived compound 113 Fig. 4 . Reduction of NO inducing activity of LPS from J774-1 cells by pre-incubation with G-EI and EIL. A total of 10 mg/ml of G-EI or EIL was mixed with 20 µg/ml of LPS. After a 3 h incubation, the mixture was diluted to 1, 10, and 100 ng/ml of LPS. J774-1 cells (1 x 10 6 cells/ml/well) were incubated with the test sample for 72 h and the supernatants were assayed for NO. NO formation was measured as the stable end product of nitrite (NO 2 -) using Griess reagent. Values represent the mean concentration of NO ± standard deviation for triplicate wells from one of three experiments with similar results. Significance and P values were obtained by paired t-test: **P <0.01 versus the LPS alone; † † P <0.01 versus the LPS/G-EI ratio. Each of the indicated concentrations of the inhibitor was mixed with 200 µg/ml of LPS. After 3 h of incubation, the mixture was diluted to indicated concentrations of LPS. Test samples in 0.1 ml pyrogen-free water were injected intraperitoneally immediately after intraperitoneal administration of 12 mg D-galactosamine in 0.5 ml pyrogen-free PBS. The corresponding concentrations of LPS alone were used as a control.
activity of LPS in this model was tested. LPS at 20 µg/ml was mixed with 10 mg/ml of either G-EI or EIL for 16 h prior to the assay, and the mixture was diluted to a concentration of 1 ng/ml of LPS. LPS solution without inhibitor was used as a positive control. The results are shown in Figure 5A . LPS alone induced strong fever in rabbit at a dose of 10 ng/kg, causing a maximum increase in temperature of 1.2°C 2 h after injection. In contrast, pyrogenicity was not observed with LPS/G-EI, or with LPS/EIL mixtures containing the same dose of LPS. No induction of fever was observed with the same mixture of LPS and EIL even at an LPS dose of 100 ng/kg, and comparable fever induction to LPS control was first observed at an LPS dose of 1 µg/kg, indicating that the pyrogenic activity of LPS was about 100-fold reduced (Fig. 5B ). Even when 20 µg/ml of LPS was mixed with 1 mg/ml of EIL, no pyrogenicity was recognized at an LPS dose of 10 ng/kg (Fig. 5A) .
Protection of mice from lethal endotoxemia by EIL
The effect of the inhibitor on lethal endotoxemia was examined using galactosamine-sensitized mice. The results are shown in Table 3 . Intraperitoneal injection of 40 ng/mouse LPS from S. minnesota exhibited 100% lethality in this system. When 1 mg of EIL in 0.1 ml of 20% ethanol/0.2 M glycine/NaOH buffer (pH 10.6) was administered intraperitoneally simultaneously, but separately, with the same dose of LPS, the majority of mice (89%) survived. This protective effect was observed even with a 10-fold increased dose (0.4 µg/mouse) of LPS (50% survival rate). Protection was also seen when 1 mg of inhibitor was given to mice 1 h before the administration of LPS (38% survival rate), but no mouse survived when the inhibitor was given 1 h after LPS challenge.
Protection of LPS-induced fever in rabbit by EIL
We monitored the suppression of fever response in rabbits to intravenously injected endotoxin by EIL without preincubation. EIL in 2 ml of 20% EtOH/0.2 M glycine/NaOH Fig. 5 . Reduction of pyrogenic activity of LPS by pre-incubation with G-EI and EIL. The same volumes of either 10 mg/ml of G-EI, or 1 and 10 mg/ml of EIL, and 20 µg/ml of LPS were mixed. After incubation for 16 h, the mixture was diluted to appropriate concentrations of LPS, and the pyrogenicity was measured. Three rabbits were used for each sample, and the mean temperature rise ± SD was calculated. In (A), the pyrogenicity of each sample containing 10 ng/kg of LPS was measured: open circles, LPS alone; filled squares, LPS pre-incubated with 10 mg/ml of G-EI; filled diamonds, LPS pre-incubated with 1 mg/ml of EIL; filled circles, LPS preincubated with 10 mg/ml of EIL. In (B), the mixture of 10 mg/ml of EIL and 20 µg/ml of LPS was diluted to the following concentrations of LPS; 10 (filled circles), 100 (filled triangles) and 1000 ng/kg (open squares), and the pyrogenicity was measured. Open circles, 10 ng/kg of LPS alone. buffer (pH 10.6) was injected intravenously just before intravenous administration of 10 ng/kg of LPS. LPS solution without the inhibitor was taken as a positive control.
The results are shown in Figure 6 . The temperature rise in rabbits injected with 5 mg/kg of EIL prior to LPS challenge was significantly lower than that in rabbits which received the same amount of LPS alone at any time of measurement. When 20 mg/kg of EIL was used, almost no pyrogenicity was expressed although a slight temperature rise was recognized later (Fig. 6 ).
DISCUSSION
Incubation of the cinnamon bark-derived inhibitor with LPS inhibited endotoxic activity of LPS in a range of in vivo and in vitro assays including: (i) the Limulus gelation assay; (ii) TNFα induction from mouse peritoneal macrophages, J774-1 cells, and human monocytic THP-1 cells; (iii) induction of NO from J774-1 cells; and (iv) lethal toxicity and pyrogenicity. This inhibitory activity was relatively stronger in the in vivo assay systems, showing 1000-fold reduction of LPS activity in lethal toxicity in mice and 100-fold reduction of fever induction in rabbits. Although we have not completely purified the inhibitor at present and could not determine its chemical structure, the active center does not appear to reside in the protein portion since it is heat stable and resistant to proteinase treatment, and it contains negligible amounts of amino acid (less than 0.1%). The inhibitor contained a significant amount of sugar (5%); however, the inhibitory activity was retained even after NaIO 4 treatment. These results, taken together with the results of the chemical analysis of G-EI and EIL, suggest that the active center of the inhibitor is in the lipid portion. This is also supported by the fact that the active fraction of G-EI shifted into the chloroform layer with chloroform separation. The inhibitor, however, was different from well-known cinnamic oil, which is a known anti-microbial component extracted from cinnamon bark by distillation, 33 since the inhibitor did not contain any of the components of cinnamic oil determined by HPLC using a reverse-phase octadecylsilane column. Furthermore, cinnamic oil and each of its components, including coumarin, cinnamomal aldehyde, cinnamyl acetate, and cinnamyl alcohol, exhibited no inhibitory activity on LPS action (data not shown).
The results obtained in the previous 22 and present studies suggest that inhibition is likely to be due to the direct interaction of the inhibitor with the LPS molecule for the following reasons. First, the inhibition was dependent on the concentrations of the inhibitor and LPS when they are mixed, not on the final concentration of the inhibitor. Second, the inhibitor suppressed all the activity of LPS in a range of assay systems in which LPS has different mechanisms of action, including the Limulus gelation activity (molecular system), TNFα and NO induction activity from various cells (cellular systems), and pyrogenicity and lethality (in vivo assay systems), indicating that it affects neither the assay systems nor the signal transduction pathway. Furthermore, inhibition was increased depending on the time of incubation of LPS and the inhibitor as shown in the previous study. It is, therefore, assumed that the inhibitor binds to LPS by a lipid-lipid interaction in direct proportion to its concentration and alters the physicochemical properties of LPS or covers the active site of lipid A and, hence, inhibits the recognition of the receptor or other molecules involved in induction of endotoxic activity.
Several compounds which bind to the LPS molecule and neutralize its action have been recently isolated from mammalian sources, including a variety of soluble serum (lipo)proteins and cationic proteins and peptides from various animals, [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [34] [35] [36] most of which are assumed to act as a first line of defense against pathogen challenge in animals. Since most of these molecules also show antimicrobial activity, they are promising for clinical applications. In our preliminary experiments, the present inhibitor from cinnamon bark also exhibited bactericidal activity. This is the first description of an inhibitor of bacterial endotoxin in plants. Although the effects of endotoxin on plants remains unknown, if endotoxin is toxic, plants would be expected to acquire such endotoxin inhibitors. It is, therefore, of interest to clarify the role of such an inhibitor in plants and to determine whether it is a common event.
Anti-endotoxin properties of a cinnamon bark-derived compound 115 Fig. 6 . Protection against LPS-induced fever in rabbit by EIL. EIL in 2 ml of 20% EtOH/0.2 M glycine/NaOH buffer (pH 10.6) was injected intravenously just before intravenous administration of 10 ng/kg of LPS, and the pyrogenicity was measured. Three rabbits were used for each sample, and the mean temperature rise ± SD was calculated.
In most cases of LPS-binding substances reported to date, protein plays a principal role in the modification of endotoxin action, and the minimal endotoxin-binding domain and chemical structure of these LPS-neutralizing substances has been examined. [37] [38] [39] [40] However, it has also been reported that the endotoxin neutralizing capacity of lipoproteins is dependent on the lipid component. 36 The mode of inhibition of LPS activity with EIL may be similar to these substances.
In addition to the inhibition of LPS activity upon incubation, the inhibitor prevented LPS effects in vivo even when it was administered prior to LPS challenge without pre-incubation, preventing death of galactosamine-sensitized mice and reducing fever in rabbits. Since the compound, especially EIL, is insoluble in water, it must be dissolved in an organic solvent such as ethanol for these experiments, and the concentration and total volume of the solvent must be limited to minimize the effect on the animals. While this may be limiting in the clinical application of the inhibitor, the high potency of this compound may facilitate its future clinical use. This compound must be purified and the chemical structure of the active center determined; this may facilitate chemical modification to, or synthesis of, a more soluble form. The purification and isolation of the active center is currently in progress in our laboratory.
Although the chemical properties of this inhibitor remain to be identified, its potent inhibitory action on LPS activity, especially the protection of animals from LPS action by pretreatment with the inhibitor, is promising for the development of agents for the treatment of diseases caused by endotoxin.
